Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN73662821
ISRCTN73662821
Completed
Not Applicable

A two-arm interventional study to evaluate the impact of Home and community management of Malaria with Artemisinin Combination Therapy (ACT) on under five childhood mortality in two rural health districts, Burkina Faso

ICEF/UNDP/World Bank/WHO - Special Programme for Research and Training in Tropical Diseases (TDR)0 sites5,000 target enrollmentNovember 25, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsncomplicated malariaInfections and InfestationsMalaria

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ncomplicated malaria
Sponsor
ICEF/UNDP/World Bank/WHO - Special Programme for Research and Training in Tropical Diseases (TDR)
Enrollment
5000
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 25, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ICEF/UNDP/World Bank/WHO - Special Programme for Research and Training in Tropical Diseases (TDR)

Eligibility Criteria

Inclusion Criteria

  • •1\. Children aged 6 to 59 months with fever (uncomplicated malaria)
  • •2\. Signs of severe disease

Exclusion Criteria

  • •1\. Known hypersensitivity to the drug
  • •2\. Refusal to give informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Role of musta aragwadhadi powder udwartana (churna massage) in childhood obesity
CTRI/2024/07/069816national institute of ayurveda
Active, not recruiting
Phase 1
A Phase 2, Interventional, Single Arm Study Describing Platelet Responses and ITPRemission Rates in Adult Subjects with Immune Thrombocytopenia Purpura ReceivingRomiplostimAdult immune thrombocytopenic purpura (ITP)MedDRA version: 12.1Level: LLTClassification code 10021245Term: Idiopathic thrombocytopenic purpura
EUCTR2010-019987-35-FRAmgen Inc75
Active, not recruiting
Phase 1
Interventional Study in Adult Subjects With Immune Thrombocytopenia Purpura Receiving Romiplostim
EUCTR2010-019987-35-GBAmgen Inc75
Active, not recruiting
Not Applicable
Interventional Study in Adult Subjects With Immune Thrombocytopenia Purpura Receiving RomiplostimAdult immune thrombocytopenic purpura (ITP)MedDRA version: 16.0Level: PTClassification code 10021245Term: Idiopathic thrombocytopenic purpuraSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2010-019987-35-CZAmgen Inc75
Active, not recruiting
Not Applicable
Interventional Study in Adult Subjects With Immune Thrombocytopenia Purpura Receiving RomiplostimAdult immune thrombocytopenic purpura (ITP)MedDRA version: 14.1Level: PTClassification code 10021245Term: Idiopathic thrombocytopenic purpuraSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2010-019987-35-DEAmgen Inc75